T he giant sarcomere protein titin has a number of important roles in cardiac muscle, where it extends an entire half-sarcomere length from the Z disk to the M line and interacts with both the thick and thin filaments. 1 Titin is a modular protein with 4 main regions: The N-terminus of titin is anchored to the Z disk of the sarcomere through interactions with T-cap and α-actinin, 2,3 as well as with the noncontractile cytoskeleton. 4, 5 The spring-like I band of titin provides the majority of passive tension in cardiomyocytes (CMs), 6, 7 whereas the rigid A-band region interacts with the thick filament and has been proposed to act as a molecular ruler that establishes the patterning of myosin. [8] [9] [10] [11] [12] The C-terminus of titin is anchored in the M line by myomesin and contains a kinase domain, which is activated by stretch to promote sarcomere protein turnover. 13, 14 Titin is known to be required for the proper function of sarcomeres. However, conflicting evidence exists about the necessity of titin in sarcomerogenesis. In cultured primary cardiomyocytes, titin is difficult to specifically and completely knock down because of its genetic complexity and large size. 15 In vivo studies of early sarcomerogenesis are challenging because of the embryonic lethality associated with homozygous truncating mutations of titin. 16, 17 Because of these roadblocks, a major unanswered question is whether titin is crucial for sarcomere formation or only necessary for proper function once sarcomeres are fully formed.
In addition to its important role in healthy CMs, heterozygous truncating mutations in the gene encoding for titin (TTN) are the leading known cause of familial dilated cardiomyopathy (DCM), accounting for ≈25% of cases. [18] [19] [20] [21] [22] Despite the high prevalence of titin-truncating mutations in patients with DCM, the pathogenicity of these mutations in the general population is not straightforward. Approximately 0.5% to 0.7% of healthy control populations carry truncating mutations in TTN, a rate at least twice that of the total prevalence of nonischemic DCM. 17, [22] [23] [24] [25] Because of the high prevalence of apparently nondeleterious titin-truncating mutations, there has been significant interest in determining whether the pathogenicity of variants can be predicted on the basis of their location within TTN. One hypothesis to predict the disease-causing potential of variants is that mutations occurring in constitutively expressed exons are more pathogenic than those in variably spliced exons. 24, 26 Although this hypothesis explains the high odds ratio of 32 for mutations in the A-band region of titin, the majority of which are constitutively spliced in, it does not account for the lower pathogenicity of truncation mutations in other constitutively expressed regions of TTN such as the Z disk, which has an odds ratio of 19.5. 17 These differences suggest that there may be other aspects of the gene architecture of TTN that have not yet been characterized that contribute to disparate clinical results of truncating mutations.
To elucidate the role of titin during sarcomere development and to better understand TTN expression, we have taken the approach of genetically engineering homozygous truncating mutations into human induced pluripotent stem cells (hiPSCs) and studying their function after differentiation into CMs (hiPSC-CMs). Genetic engineering in vitro allows the dissection of titin-specific effects at early developmental stages that would not be possible with animal models. Understanding titin expression and function in hiPSC-CMs is especially important because these cells are often used to study heterozygous titin-truncating mutations for disease modeling. [26] [27] [28] Because heterozygous truncating mutations in the Aband region of titin are more pathogenic than those in the Z disk region, we introduced homozygous truncating mutations in each of these locations to determine whether they caused different phenotypes. A previous study of hiPSC-CMs carrying a homozygous A-band titin truncation found that the cells lacked sarcomeres, 26 and because of the embryonic lethality of homozygous titin truncations in both the Z disk and A band in animal models, 16, 17 we hypothesized that both mutations would prevent sarcomere formation in hiPSC-CMs. Although A-band truncations blocked sarcomere formation, we were surprised to find that CMs with Z disk truncations formed sarcomeres and visibly contracted, albeit much
Clinical Perspective
What Is New?
• Our studies using genetically engineered human induced pluripotent stem cell derived cardiomyocytes experimentally confirm that the gene encoding the giant sarcomere protein titin (TTN) includes an internal promoter and start site. • This internal start site encodes for the isoform Cronos, which we demonstrate is able to support some sarcomere formation in human induced pluripotent stem cell derived cardiomyocytes. • To the best our knowledge, this is the first study to experimentally demonstrate that Cronos is expressed in fetal and adult cardiac tissue and is necessary for proper human cardiomyocyte function.
What Are the Clinical Implications?
• Truncating mutations in TTN are the leading known cause of familial dilated cardiomyopathy. • Cronos titin is a previously unstudied form of titin that we show is necessary for normal human cardiomyocyte function and could be contributing to these titinopathies. • Truncating mutations in TTN are most often found in the regions of the gene included in Cronos titin, warranting further investigation into its role in dilated cardiomyopathy pathogenesis.
ORIGINAL RESEARCH ARTICLE more weakly than wild type (WT) hiPSC-CMs. Sarcomere assembly in Z disk truncations was associated with the expression of Cronos, a newly described titin isoform with a start site downstream of the truncating mutation in these cells. 29 In contrast, this isoform is absent (or truncated) in A-band truncations, where sarcomere formation is not observed. We further show that Cronos is highly expressed in developing human hearts and may be involved in sarcomerogenesis. When Cronos is specifically knocked out in hiPSC-CMs, the cells produce lower contractile force and develop sarcomeric disarray despite the presence of full-length titin. We conclude that Cronos titin is expressed in human CMs and is necessary for normal sarcomere formation and function.
METHODS
The data, analytical methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure.
CRISPR/Cas9 Targeting of TTN in hiPSCs
Single guide RNAs targeting TTN exons 2 and 326 and the Cronos-specific region were designed with the online CRISPR design tool (crispr.mit.edu; single guide RNA sequences are listed in Table I 
Cardiac Differentiation
WT and mutated WTC11 hiPSCs were differentiated into CMs using a previously described monolayer protocol 31 (details in Methods in the online-only Data Supplement) and maintained in RPMI media (Gibco) supplemented with 2% B-27 with insulin (Life Technologies) and 1% penicillin/streptomycin (Invitrogen). For single-cell force, calcium, and morphology measurements and live-cell imaging, CMs were purified with lactate selection by replating cells 14 to 18 days after the start of differentiation and feeding with DMEM without glucose (Gibco) supplemented with 4 μmol/L sodium lactate (Sigma-Aldrich) on days 18 to 22 after differentiation. 32 Cells used for calcium and morphology measurements were cultured in media containing 10 μmol/L cytosine β-D-arabinofuranoside (Sigma-Aldrich) for 2 days after replating as single CMs.
Engineered Heart Tissues
Engineered heart tissues (EHTs) were cast 23 to 32 days after the start of differentiation with the use of a previously described fibrin scaffold system. 33 Each EHT was seeded with 4×10 5 hiPSC-CMs and 4×10 4 HS27a bone marrow stromal cells (ATCC) resuspended in 100 μL fibrin solution and cast between 1 rigid and 1 flexible post made from silicone rubber (polydimethylsiloxane, Sylgard 184). EHTs were maintained in RPMI media supplemented with 2% B-27 with insulin, 1% penicillin/streptomycin, and 5 mg/mL aminocaproic acid (Sigma-Aldrich), which was changed every 2 to 3 days. After 3 weeks in culture, the deflection of the flexible posts during 1.5-Hz pacing was tracked by light microscopy. Force was calculated by multiplying the flexible post stiffness (k=0.95 μN/μm) by the measured post deflection, and the twitch kinetics were obtained from the force profiles.
Live-Cell Imaging
hiPSC-CMs were transduced with ELF1a-mCherry-a-actinin lentivirus ranging from days 23 to 35 after differentiation. Viral medium was changed 24 hours after transduction. Cells recovered for 6 days with regular maintenance and then were replated for imaging as described in the Methods in the online-only Data Supplement.
Statistical Analysis
For assays with 2 groups, Student t tests were performed in Excel. For assays with >2 groups, 1-way ANOVAs were performed in MATLAB with the anova1 function, and if the returned P value was <0.01, a Tukey post hoc analysis was performed with the multcompare function. Adjusted P values were computed with the Benjamini and Hochberg method.
Institutional Review Board
The studies for this articles did not include any human or animal studies. Thus, Institutional Review Board approval was not required.
RESULTS

Human iPSC Line Generation, Differentiation, and Titin Expression
To investigate the role of titin truncation mutations in CM differentiation and sarcomerogenesis, the CRISPR/ Cas9 system was used to introduce truncation mutations via nonhomologous end joining into the WTC11 hiPSC line. 34 Mutations were targeted in exon 2 (in the Z disk domain; TTN-Z −/− ) and exon 326 (in the A-band region; TTN-A −/− ) of TTN using 2 different guide RNAs and generating 2 separate clonal lines for each locus ( Figure 1A ). Both of these exons are constitutively expressed in CMs but not in pluripotent cells. 26 Singlecell colonies were expanded and screened for homozygous mutations that introduce a stop codon and are thus expected to cause truncations. All mutant cell lines had normal karyotypes and normal colony morphology and growth ( Figure I in the online-only Data Supplement). After induction with activin A, BMP4, and small-molecule Wnt modulators, all lines differentiated into high-purity populations of CMs as measured by flow cytometry after staining for cardiac troponin T
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( Figure 1B ). Given that we had hypothesized that none of the mutant cell lines would develop sarcomeres, we were surprised to find that the TTN-Z −/− lines, which cause the most proximal truncation, formed monolayers of beating CMs. The TTN-A −/− lines did not visibly contract, even in populations that had a high percentage of cardiac troponin T-positive cells. Because TTN-Z −/− -CMs visibly contracted, we hypothesized that these cells were expressing some form of titin that allowed them to form functioning sarcomeres. Levels of full-length titin transcript were not significantly different across any of the cell lines, indicating that nonsense-mediated decay of the TTN transcript does not occur ( Figure IIB in the online-only Data Supplement). To investigate titin expression, we performed immunocytochemistry on hiPSC-CMs with antibodies to probe for the Z disk, distal I-band, and M-line domains of titin ( Figure 1C ). WT samples stained positively for all 3 titin epitopes, and the antibodies localized within the sarcomere in the expected patterns. TTN-Z −/− -CMs exhibited striated staining with α-actinin, and interestingly, these sarcomeres stained positively only for distal I-band and M-line titin, both of which are downstream of the mutation introduced into this cell line. Finally, TTN-A −/− -CMs did not form distinct sarcomeres, and diffuse α-actinin, Z disk, and I-band titin signals were observed. The M-line domain of titin, which is downstream of the mutation in these cells, was not detected. These data indicate that despite inducing a truncating mutation in a constitutively expressed N-terminal exon, the TTN Z −/− cells expressed distal elements of TTN that supported myofibrillogenesis and contractility.
Titin Z Disk Truncations Are Partially Rescued by Cronos Titin
The expression of distal titin epitopes with Z disk truncation mutations suggested that an alternative transcript ORIGINAL RESEARCH ARTICLE was initiated 3' to our mutations. Zou et al 29 recently identified an internal promoter in zebrafish ttn, which initiates transcription from a previously unrecognized transcriptional start site located in the distal I-band portion. 29 Called Cronos, this C-terminal isoform of titin is predicted to be approximately two-thirds the size of the full-length isoforms and to contain the distal I-band, Aband, and M-line regions, consistent with our epitope maps in the Z disk truncation lines (Figure 2A ). Gene targeting approaches disrupting Cronos titin expression in zebrafish cause significant myofibrillar disarray. 29 Although the transcript has been detected in mammalian cardiac samples, 29 until now, no studies have identified the Cronos titin protein or investigated its role in human CMs. We hypothesized that the TTN-Z −/− -CMs express Cronos titin, which allowed some sarcomere formation in these cells.
To begin investigating this hypothesis, we revisited chromatin immunoprecipitation sequencing data from human embryonic stem cells undergoing cardiac differentiation. 35 We identify 2 peaks of H3K4me3 (a promoter-specific epigenetic mark) within TTN in definitive CMs 14 days after the start of differentiation that are not present during earlier stages of differen- 
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tiation ( Figure 2B ). One peak localizes to the 5' end of TTN corresponding to the transcriptional start site of full-length titin, and the second prominent peak corresponds to the locus previously proposed for the Cronos titin transcriptional start site in the intron between exons 240 and 241 ( Figure 2C ). Profiles for the repressive H3K27me3 chromatin mark did not show significant peaks in the TTN locus at any time point studied ( Figure  IIA in the online-only Data Supplement). The appearance of H3K4me3 deposition without H3K27me3 is a pattern typically observed in cardiac structural genes. 31 Together, these provide genomic evidence to support the presence of an internal Cronos-specific promoter within the TTN locus in human stem cell-derived CMs.
To determine whether Cronos titin protein was present in hiPSC-CMs, we performed loose gel electrophoresis to distinguish titin isoforms by molecular weight. Analysis of total protein with a Coomassie stain indicates that both N2BA and T2 titin are present in WT samples but only T2 titin is present in TTN-Z −/− cells ( Figure 2D ). The T2 band has previously been described as a proteolytic degradation product of N2B and N2BA titin, [36] [37] [38] but we and others hypothesized that this band contains the novel isoform Cronos because of its similar expected molecular weight (≈2.2 MDa). 29 To test this idea, we raised a custom antibody to recognize the N-terminus of Cronos, the first 13 residues of which are specific to this isoform 29 (see Methods in the online-only Data Supplement for details). Western blots against hiPSC-CM lysates and human adult left ventricular tissue with this antibody labeled the T2 band but did not detect any of the other titin isoforms present, confirming that this band includes Cronos titin. The Cronos titin band was also recognized by antibodies for the A-band/Iband junction and M-line regions of titin ( Figure IIC in the online-only Data Supplement). Several lower-weight titin bands were detected in the TTN-A −/− -CMs on the Coomassie-stained gel and Cronos titin Western blot, indicating that only truncated versions of N2BA and Cronos titin are present in these cells. Taken together, these data demonstrate that the T2 band includes Cronos titin, indicate that this novel isoform is expressed in hiPSC-CMs and human heart tissue, and reveal that TTN-Z −/− CMs are solely expressing this isoform.
To investigate whether Cronos titin was being integrated into sarcomeres and to establish its localization in the cell lines, we performed immunostaining with our custom antibody ( Figure 2E ). This revealed doublet patterns surrounding the Z disks in both WT and TTN-Z −/− samples, demonstrating that Cronos titin is being expressed and integrated into sarcomeres in these cells. TTN-A −/− samples stained diffusely for Cronos titin, similar to the pattern observed with other titin antibodies that recognize regions upstream of the truncating mutation. This pattern is also consistent with Western blot data indicating that the TTN-A −/− cells are expressing a large truncation product of this isoform. Thus, we conclude that the ability of TTN-Z −/− mutants to form sarcomeres likely results from the ability of Cronos to substitute, at least in part, for full-length titin.
Force Production in EHTs and Single Cells
After observing that TTN-Z −/− -CMs can form sarcomeres and contract with Cronos used as a substitute for fulllength titin, we were interested in establishing whether they had contractility comparable to that of WT cells. To investigate force production, we characterized the contractile function of WT and mutant CMs in a multicellular context using EHTs 33 and as single cells. 39 Consistent with observations of CMs in monolayers, both WT and TTN-Z −/− EHTs visibly contracted, whereas TTN-A −/− EHTs did not visibly contract, although they did compact the fibrin gel. Measurements of paced twitches 3 weeks after seeding indicate that TTN-Z −/− EHTs produced only ≈10% of absolute force produced by WT EHTs (Figure 3A and 3B) and ≈25% of active tension compared with WT ( Figure 3C) . The time to peak WT and TTN-Z −/− EHT twitches was slightly decreased, although the maximum rate of force development was dramatically slower ( Figure IIIF and IIIG in the online-only Data Supplement). Neither 50% or 90% relaxation time was significantly different in TTN-Z −/− EHTs, although passive force was significantly decreased (Figure IIIB , IIID, and IIIE in the online-only Data Supplement). Staining for different regions of titin indicated that titin expression was the same in EHTs as in single cells ( Figure IV in the online-only Data Supplement). Taken together, these data indicate that although TTN-Z −/− -CMs are able to form sarcomeres and contract, they produce only a small fraction of the force of WT cells in engineered tissues.
To determine whether the weak force production of TTN-Z −/− EHTs was caused by attenuated twitches of individual cells, we characterized single-cell contractility using a micropost-based assay system 39 (Figure 3D through 3F) . Interestingly, maximum twitch velocity, twitch power, cell size, and passive force were not different between cell types, although both upstroke and relaxation times were decreased in TTN-Z −/− -CMs compared with controls ( Figure 3G and Figure V in the online-only Data Supplement). Notably, the force difference between single WT-CMs and TTN-Z −/− -CMs is less dramatic than that observed in the EHT system. This may be partially caused by the younger age and less mature state of cells used in the micropost system, along with the fact that multicellular forces are generated in series in the EHTs, which would be expected to increase the difference between WT and knockout (KO) cells (see Discussion). 
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To determine whether the reduced force produced by TTN-Z −/− -CMs was caused by differences in calcium handling, we measured Ca 2+ transients during electric pacing of single cells plated on fibronectin-coated glass slides ( Figure VI in the online-only Data Supplement). Interestingly, we found that the magnitude of calcium transients in TTN-Z −/− and TTN-A −/− CMs was not lower than in WT controls, although some calcium release was slightly slower and reuptake was slightly faster in some groups. From these data, we conclude that differences in calcium transients do not explain attenuated force production observed in individual TTN-Z −/− -CMs.
Cell Morphology and Sarcomere Formation
To measure whether sarcomere morphology was distinct between WT and TTN-Z −/− -CMs, we fixed and stained cells after 30 and 60 days of culture on nanopatterned substrates, which provide external cues to improve elongation and sarcomere alignment. 40, 41 Myofibrils in TTN-Z −/− cells were noticeably sparser compared with WT controls, and maximum myofibril bundle width within each cell was less than half of control at both time points ( Figure 4A and 4B ). In addition, although WT myofibril bundle width significantly increased between 30 and 60 days cultured on the nanopatterns, indicative of continued hypertrophy and increasing organization, it did not change in TTN-Z −/− -CMs. This could indicate that TTN-Z −/− myofibril bundling or stability is compromised. Interestingly, sarcomere length, circular variance (a measure of sarcomere disarray), cell area, maximum cell width, and cell length were not significantly different between WT and TTN-Z −/− -CMs at either time point ( Figure VIIA through VIIC, VIIF, and VIIG in the online-only Data Supplement). In addition, the TTN-Z −/− -CMs exhibited higher multinucleation than WT controls at the 60day time point. Although overall rates of multinucleation were nonsignificantly higher in TTN-Z −/− cells at 
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this time point, there were striking incidences of cells that contained 4 or 5 nuclei ( Figure VIID and VIIE in the online-only Data Supplement). This was never observed in the WT samples and may be explained by a nuclear role of full-length titin or a cytoplasmic role in inhibiting nuclear division. [42] [43] [44] To further investigate sarcomere formation in TTN-Z −/− -CMs, we lentivirally transduced CMs with mCherrytagged α-actinin, replated the cells, and performed livecell imaging every 30 minutes for 12 hours. WT CMs exhibited the expected peripheral flow of α-actinin in stress fiber-like structures at the edge of the cell, which then became centripetal as the α-actinin condensed and formed Z disks near the center of the cell, as previously reported. 45 During the 12 hours of imaging, a drastic increase in myofibril number and bundle width was observed in WT-CMs ( Figure 4C 
Expression of Cronos in Human Fetal and Adult Hearts
Having established Cronos titin expression and integration into sarcomeres in hiPSC-CMs, we wanted to examine whether this isoform was similarly expressed in human tissue. To study the expression levels and localization of Cronos titin in development, we performed immunohistochemistry on human fetal and adult cardiac ventricular samples using our Cronos titin-specif-ic antibody ( Figure 5A ). Staining for β-myosin heavy chain revealed clear striations in all samples studied, with increasing density and alignment of myofibrils in older fetal and adult samples. Cronos titin staining was clearly visible throughout the tissue of day 54 and 81 fetal heart samples. As in the hiPSC-CMs, Cronos formed doublets within the sarcomere of fetal hearts, corresponding to the space between the thick filament and the Z disk. Myofibril density and Cronos titin staining were noticeably higher in the day 81 than in the day 54 sample. Interestingly, Cronos titin staining was drastically reduced in the day 130 fetal sample, in which it was barely visible in isolated portions of the 
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tissue. In sections where Cronos titin was observed, it remained in a striated pattern but had lost the doublet pattern detected in earlier fetal samples. Adult tissue did not show a clear pattern of Cronos titin localization, and the signal was barely above background fluorescence observed in unstained tissue ( Figure VIII in the online-only Data Supplement). Cronos and full-length titin transcripts were detected in adult and fetal cardiac samples, and although low sample numbers limit statistical analysis, Cronos appears to be more highly expressed in fetal than in adult tissue ( Figure 5B and  5C ). In addition, chromatin immunoprecipitation sequencing data indicate that a fetal whole-heart sample has H3K4me3 peaks at both the full-length and Cronos transcription start sites in TTN, similar to that observed in hPSC-CM samples, whereas adult LV samples have peaks only at the full-length start site ( Figure 5D ). These data confirm that Cronos titin is highly expressed in human fetal cardiac tissue.
Cronos Titin Is Necessary for Organized Sarcomere Formation
To investigate the role of Cronos titin in CM function and sarcomere formation, we generated 2 Cronos KO hiP-SC lines, both of which expressed full-length titin. Both hiPSC lines differentiated into visibly beating CMs, and immunostaining for Cronos indicated that none was integrated into sarcomeres ( Figure 6A ), whereas staining showed that domains present in full-length titin were still present and correctly localized relative to α-actinin ( Figure IX in the online-only Data Supplement). A Western blot using the custom Cronos titin antibody indicated that this isoform was absent in the Cronos KO-CM ( Figure 6B and Figure To elucidate the cause of reduced force development, we performed immunohistochemistry on the WT and Cronos EHTs and measured sarcomere length and circular variance, a measure of myofibril alignment. Although sarcomere length was no different between the groups, the myofibrils of the Cronos KO EHTs had significantly more disarray compared with WT ( Figure 6D  and 6E ). In addition, single-cell measurements indicated that there was no significant difference in the magnitude of calcium transients, although the maximum rate of calcium release was slower ( Figure XI in the onlineonly Data Supplement). This indicates that the reduced force production in hiPSC-CMs lacking Cronos titin may result from myofibril disarray.
DISCUSSION
To assess the role of titin in the formation of sarcomeres, we generated 2 hiPSC lines with homozygous mutations in constitutively expressed exons of TTN. We hypothesized that proximal truncations (TTN-Z −/− ) would produce more severe phenotypes than distal truncations (TTN-A −/− ). Instead, we found that the proximal truncation mutations were compatible with myofibril assembly and contraction, whereas the distal truncations had neither myofibrils nor contractility. Using a customgenerated antibody, we determined that TTN-Z −/− -CMs express the Cronos titin isoform, which appears to initiate transcription from an internal promoter distal to the truncation and is sufficient to support some sarcomere formation. In contrast, TTN-A -/ -CMs express what are likely truncations of both full-length and Cronos titin and do not form myofibrils, as has been previously reported. 26 This study also reported that hiPSC-CMs carrying a homozygous truncation in the early I-band region of titin can form sarcomeres. However, this mutation was in an exon that is only sometimes spliced in, and the sarcomere formation was associated with splicing out the mutated exon. 26 In the present study, the engineered Z disk mutations are in a constitutively expressed exon, ruling out variable splicing as a mechanism of escape. Thus, we conclude that Cronos titin is sufficient for some sarcomere formation and that the absence of both full-length and Cronos titin inhibits sarcomerogenesis. Although a dominant-negative effect of the large N-terminal fragments in TTN-A −/− -CMs cannot be ruled out from our data, experiments in zebrafish using a combined CRISPR/Cas9 knockout and morpholino knockdown implicate a deficiency of titin rather than a dominant-negative effect. 29 In addition, alternative splicing or other internal start sites in titin could not have been detected by the methods in this study and will require follow-up experiments to assess in this system. Our data are consistent with a structural role for titin, in particular the C-terminal regions, in sarcomere formation. Signaling roles cannot be ruled out, however, given that titin has multiple functions. For example, it is possible that the absence of the M-line region of titin disrupts signaling pathways dependent on the titin kinase domain, which is involved in protein turnover and hypertrophy. 14 However, several pieces of evidence suggest that this is not the case. Previously, a mouse embryonic stem cell line with a homozygous truncating mutation in the M-line region of titin preventing expression of both the kinase domain and C-terminus of the protein was found to lack sarcomeres when differentiated into CMs. 47 However, a mouse model harboring a mutation that deletes the kinase domain but not the C-terminal of the protein was observed to form sarcomeres early in embryonic development. 48 This indicates that it may be the anchoring function of the carboxy terminus of titin, rather than the kinase function, that is required for sarcomere formation. This notion is consistent with our finding that cardiac troponin T and α-actinin protein are both diffusely present in TTN-A −/− -CMs and indicates that sarcomeric proteins may still be expressed but cannot assemble into functional units. This suggests that signaling pathways relying on M-line titin may not be crucial for sarcomeric protein expression, whereas other functions of this domain such as anchoring to myomesin may be important for this stage of development.
TTN-Z −/− -CMs produced lower force as both multicellular EHTs and single cells compared with WT CMs, although calcium transients had similar magnitudes. Interestingly, the force deficit of individual cells was not as dramatic as in EHTs. One potential explanation for this could be the greater maturity of the CMs in EHTs compared with monolayers, 49 such that differences in the rate and extent of myofibril formation and bundling in cells become more pronounced. Another possibility is that the summation of cellular forces in series in tissue compared with single-cell assays is compounding differences in force production or that there is more compliance between coupled cells in TTN-Z −/− EHTs compared with WT.
Staining of human tissue indicated that Cronos titin is most highly expressed in early fetal cardiac tissue, suggesting that it is predominantly a developmental isoform. The T2 band, which we demonstrate includes Cronos titin, has been shown to consistently decrease in intensity in cardiac samples as animals mature 36 and as hiPSC-CMs are aged in culture, 26 supporting the notion that Cronos titin is predominantly a developmental isoform. Because hiPSC-CMs mature more rapidly in ORIGINAL RESEARCH ARTICLE three-dimensional culture compared with two-dimensional culture, 50 cells in the EHTs may be more mature and thus express more full-length titin, whereas single cells on microposts are younger and thus may be expressing mostly Cronos titin. The passive tension measured in individual TTN-Z −/− -CMs was not significantly different compared with WT cells ( Figure 5D ). This could be explained by the immaturity of the contractile lattice in these cells; fetal cardiac tissue has very low passive tension, especially from titin contributions. 36, 51, 52 Our recent studies have indicated that hiPSC-CMs matured for 80 to 100 days on patterned substrates have contractile properties similar to those of 74-day fetal tissue, 41 and because the cells used in the micropost assay were significantly younger than this (35-40 days after differentiation), it is likely that they were less mature. Thus, it is possible that the passive tension being measured from singlecell hiPSC-CMs on the microposts results predominantly from other sources such as nonmuscle actin filaments or intermediate filaments within the cells. 6 Morphological analysis of the myofibrils indicated that TTN-Z −/− had smaller myofibril bundle widths at the Z disk compared with WT ( Figure 4B ), suggesting either smaller diameters of individual myofibrils or fewer myofibrils in parallel. Previously, conflicting data have been reported on the necessity of N-terminal titin for the formation of Z disks, 2, 53 and the present study indicates that Z disks are able to form in the absence of the N-terminus of titin. However, the live-cell images of cells expressing tagged α-actinin indicate that the stability or bundling ability of these Z disks is compromised, and they quickly degrade after they are formed. We found that sarcomere length was not significantly different between WT and TTN-Z −/− -CMs, which could indicate that full-length titin is not a major contributor to determining sarcomere length in cells at this stage of maturation. Supporting this notion, the length of Iband titin, which is missing in TTN-Z −/− -CMs, does not influence thin filament length, even in adult mice. 54 For the first time in human cells, we have knocked out Cronos titin. The resulting CMs exhibit reduced force production and sarcomeric disarray, similar to what was observed in zebrafish. 29 Cronos is highly expressed in fetal cardiac tissue samples and appears to have a role in sarcomere formation or stability, particularly in the thick filament, given its likely interaction through the included A-band domains. Although further experiments are necessary to understand the role of this isoform in normal human development, these findings indicate that Cronos is an important player in sarcomerogenesis.
It is striking that CMs are able to form sarcomeres in the absence of full-length titin in TTN-Z −/− -CMs, given that these mutations are not compatible with survival in rodent models. 16, 17 We conclude that sarcomeres form in TTN-Z −/− -CMs and not TTN-A −/− -CMs because of the presence of Cronos titin, an isoform of titin that we demonstrate for the first time is expressed and integrated into myofibrils of human CMs. According to the findings of this study, it is likely that Cronos is a developmental isoform of titin. We conclude that Cronos titin is necessary for normal sarcomere development and function because full Cronos KO CMs produce lower contractile force and disarrayed sarcomeres. The discovery of this isoform in human samples motivates a closer look at how DCM is caused by truncating mutations in TTN and the potential role of Cronos in DCM pathogenesis. In particular, the presence of Cronos titin should be taken into account in the evaluation of hiPSC models of DCM because this isoform clearly plays a significant role in hiPSC-CM function. Elucidating the functions of Cronos titin in human development and DCM will be crucial for fully understanding heart development and disease.
